Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension

Hypertension Research

Volumn 32, Issue 5, 2009, Pages 411-418

  Yoshida, Tetsuro ^a   Kato, Kimihiko ^b   Yokoi, Kiyoshi ^b   Watanabe, Sachiro ^b   Metoki, Norifumi ^c   Satoh, Kei ^d   Aoyagi, Yukitoshi ^e   Nishigaki, Yutaka ^e   Nozawa, Yoshinori ^f   Yamada, Yoshiji ^g  

^a Inabe General Hospital   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c Hirosaki Stroke Center   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^f GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^g MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACETYL COENZYME A ACETYLTRANSFERASE 2; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID BINDING PROTEIN 2; GAP JUNCTION ALPHA 4 PROTEIN; GAP JUNCTION PROTEIN; HEME OXYGENASE 1; INTERLEUKIN 10; INTERSTITIAL COLLAGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; WERNER SYNDROME PROTEIN;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 68249159779     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.22     Document Type: Article

References (31)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1): S1-S266.
2. Wainer DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
3. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD Study Group. Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252.
4. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int 2007; 71: 159-166.
5. Kes F, Ratković-Gusić I. The role of arterial hypertension in progression of renal failure. Kidney Int Suppl 1996; 55: S72-S74.
6. Porush JG. Hypertension and chronic renal failure: The use of ACE inhibitors. Am J Kidney Dis 1998; 31: 177-184.
7. Norris KC, Tareen N, Martins D, Vaziri ND. Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans. Nat Clin Pract Nephrol 2008; 4: 538-549.
8. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008; 121: 332-340.
9. Palmer BF Management of hypertension in patients with chronic kidney disease and diabetes mellitus. Am J Med 2008; 121: S16-S22.
10. Barri YM. Hypertension and kidney disease: A deadly connection. Curr Hypertens Rep 2008; 10: 39-45.
11. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, limuro S, Ohashi Y, Hishica A, CKD-JAC Study Group. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: Design and methods. Hypertens Res 2008; 31: 1101-1107.
12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
13. Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005; 57: 717-729.
14. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 1995; 57: 289-300.
15. Bernard S, Charrière S, Charcosset M, Berthezène F, Moulin P, Sassolas A. Relation between XbA1 apolipoprotein B gene polymorphism and cardiovascular risk in a type 2 diabetic cohort. Atherosclerosis 2004; 175: 177-181.
16. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987; 31: 1153-1159.
17. Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 1988; 8: 261-271.
18. Song J, Sakatsume M, Narita I, Goto S, Omori K, Takada T, Saito N, Ueno M, Gejyo F. Peroxisome prolifierator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. Clin Genet 2003; 64: 398-403.
19. Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, Amouyel P. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 2003; 23: 289-294.
20. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999; 65: 1647-1655.
21. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-267.
22. Thibaudin D, Thibaudin L, Berthoux P, Mariat C, Filippis JP, Laurent 8, Alamartine E, Berthoux F. TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. Kidney Int 2007; 71: 431-437.
23. Buraczynska M, Mierzicki P, Buraczynska K, Dragan M, Ksiazek A. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol Diagn Ther 2007; 11: 257-263.
24. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, Mcllroy SP, Passmore AR Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: A case-control study. Lancet 2001; 357: 436-439.
25. Ye L, Miki T, Nakura J, Oshima J, Kamino K, Rakugi H, Ikegami H, Higaki J, Edland SD, Martin GM, Ogihara T. Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population. Am J Med Genet 1997; 68: 494-498.
26. Morita H, Kurihara H, Sugiyama T, Hamada C, Yazaki Y. A polymorphic variant C1367R of the Werner helicase gene and atherosclerotic diseases in the Japanese population. Thromb Haemost 1999; 82: 160-161.
27. Lambert JC, Brousseau T, Defosse V, Evans A, Arveiler D, Ruidavets JB, Haas B, Cambou JP, Luc G, Ducimetière P, Cambien F, Chartier-Harlin MC, Amouyel P. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - the ECTIM study. Hum Mol Genet 2000; 9: 57-61.
28. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003; 42: 1429-1437.
29. Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC. Cyclooxygenase polymorphisms and risk of cardiovascular events: The Atherosclerosis Risk in Communities (ARIC) study. Clin Pharmacol Ther 2008; 83 52-60.
30. He X, Lu Y, Saha N, Yang H, Heng CK. Acyl-CoA: Cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks. Hum Genet 2005; 118 393-403.
31. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-1672.